Am J Perinatol
DOI: 10.1055/a-1817-5788
Original Article

Maternal Diabetes and Intrapartum Fetal Electrocardiogram

1   Department of Obstetrics and Gynecology of Northwestern University, Chicago, Illinois
,
Steven J. Weiner
2   the George Washington University Biostatistics Center, Washington, Dist. Of Columbia
,
George R. Saade
3   University of Texas Medical Branch, Galveston, Texas
,
Michael A. Belfort
4   University of Utah Health Sciences Center, Salt Lake City, Utah
,
Sean C. Blackwell
5   University of Texas Health Science Center at Houston, McGovern Medical School-Children's Memorial Hermann Hospital, Houston, Texas
,
John M. Thorp Jr.
6   University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
,
Alan T. N. Tita
7   University of Alabama at Birmingham, Birmingham, Alabama
,
Russell S. Miller
8   Columbia University, New York, New York
,
David S. McKenna
9   The Ohio State University, Columbus, Ohio
,
Edward K. S. Chien
10   MetroHealth Medical Center-Case Western Reserve University, Cleveland, Ohio
,
Dwight J. Rouse
11   Brown University, Providence, Rhode Island
,
Yasser Y. El-Sayed
12   Stanford University, Stanford, California
,
Yoram Sorokin
13   Wayne State University, Detroit, Michigan
,
Steve N. Caritis
14   University of Pittsburgh, Pittsburgh, Pennsylvania
,
for the Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units (MFMU) Network* › Institutsangaben

Abstract

Objective Fetal electrocardiogram (ECG) ST changes are associated with fetal cardiac hypoxia. Our objective was to evaluate ST changes by maternal diabetic status and stage of labor.

Methods This was a secondary analysis of a multicentered randomized-controlled trial in which laboring patients with singleton gestations underwent fetal ECG scalp electrode placement and were randomly assigned to masked or unmasked ST-segment readings. Our primary outcome was the frequency of fetal ECG tracings with ST changes by the stage of labor. ECG tracings were categorized into mutually exclusive groups (ST depression, ST elevation without ST depression, or no ST changes). We compared participants with DM, gestational diabetes mellitus (GDM), and no DM.

Results Of the 5,436 eligible individuals in the first stage of labor (95 with pregestational DM and 370 with GDM), 4,427 progressed to the second stage. ST depression occurred more frequently in the first stage of labor in participants with pregestational DM (15%, adjusted odds ratio [aOR] 2.20, 95% confidence interval [CI] 1.14–4.24) and with GDM (9.5%, aOR 1.51, 95% CI 1.02–2.25) as compared with participants without DM (5.7%). The frequency of ST elevation was similar in participants with pregestational DM (33%, aOR 0.79, 95% CI 0.48–1.30) and GDM (33.2%, aOR 0.91, 95% CI 0.71–1.17) as compared with those without DM (34.2%). In the second stage, ST depression did not occur in participants with pregestational DM (0%) and occurred more frequently in participants with GDM (3.5%, aOR 2.01, 95% CI 1.02–3.98) as compared with those without DM (2.0%). ST elevation occurred more frequently in participants with pregestational DM (30%, aOR 1.81, 95% CI 1.02–3.22) but not with GDM (19.0%, aOR 1.06, 95% CI 0.77–1.47) as compared with those without DM (17.8%).

Conclusion ST changes in fetal ECG occur more frequently in fetuses of diabetic mothers during labor. ClinicalTrials.gov number, NCT01131260.

Precis: ST changes in fetal ECG, a marker of fetal cardiac hypoxia, occur more frequently in fetuses of diabetic parturients.

Key Points

  • Fetal hypertrophic cardiomyopathy (HCM) and cardiac dysfunction occur frequently among fetuses of diabetic patients.

  • Fetal ECG changes such as ST elevation and depression reflect cardiac hypoxia.

  • Fetuses of diabetic patients demonstrate a higher prevalence of fetal ECG tracings with ST changes.

* See Appendix for a list of other members of the NICHD MFMU Network


Note

The project described was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD34208, HD53097, HD40545, HD40560, HD27869, HD40485, HD40512, HD27915, HD40544, HD40500, HD68282, HD68268, HD27917, HD21410, HD36801] and by funding from Neoventa Medical. Comments and views expressed in this article are those of the authors and do not necessarily represent the views of the NICHD. Neoventa Medical did not participate in the monitoring of the study; data collection, management, or analysis; or manuscript preparation.

Presented in part at the Society for Maternal-Fetal Medicine's 39th Annual Pregnancy Meeting, February 11 to 16, 2019, Las Vegas, Nevada.




Publikationsverlauf

Eingereicht: 08. September 2021

Angenommen: 22. März 2022

Accepted Manuscript online:
05. April 2022

Artikel online veröffentlicht:
10. Juli 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Hökegård KH, Eriksson BO, Kjellmer I, Magno R, Rosén KG. Myocardial metabolism in relation to electrocardiographic changes and cardiac function during graded hypoxia in the fetal lamb. Acta Physiol Scand 1981; 113 (01) 1-7
  • 2 Westgate JA, Bennet L, Brabyn C, Williams CE, Gunn AJ. ST waveform changes during repeated umbilical cord occlusions in near-term fetal sheep. Am J Obstet Gynecol 2001; 184 (04) 743-751
  • 3 Hökegård KH, Karlsson K, Kjellmer I, Rosén KG. ECG-changes in the fetal lamb during asphyxia in relation to beta-adrenoceptor stimulation and blockade. Acta Physiol Scand 1979; 105 (02) 195-203
  • 4 Hökegård KH, Rosén KG. Alterations in the electrocardiogram of the fetal lamb as a sign of fetal asphyxia. A comparison between the scalp lead and the precordial lead. Acta Obstet Gynecol Scand 1980; 59 (05) 411-415
  • 5 Rosén KG, Hökegård KH, Kjellmer I. A study of the relationship between the electrocardiogram and hemodynamics in the fetal lamb during asphyxia. Acta Physiol Scand 1976; 98 (03) 275-284
  • 6 Westgate J, Harris M, Curnow JS, Greene KR. Randomised trial of cardiotocography alone or with ST waveform analysis for intrapartum monitoring. Lancet 1992; 340 (8813): 194-198
  • 7 Ojala K, Vääräsmäki M, Mäkikallio K, Valkama M, Tekay A. A comparison of intrapartum automated fetal electrocardiography and conventional cardiotocography—a randomised controlled study. BJOG 2006; 113 (04) 419-423
  • 8 Vayssière C, David E, Meyer N. et al. A French randomized controlled trial of ST-segment analysis in a population with abnormal cardiotocograms during labor. Am J Obstet Gynecol 2007; 197 (03) 299.e1-299.e6
  • 9 Westerhuis MEMH, Visser GHA, Moons KGM. et al. Cardiotocography plus ST analysis of fetal electrocardiogram compared with cardiotocography only for intrapartum monitoring: a randomized controlled trial. Obstet Gynecol 2010; 115 (06) 1173-1180
  • 10 Amer-Wåhlin I, Hellsten C, Norén H. et al. Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial. Lancet 2001; 358 (9281): 534-538
  • 11 Belfort MA, Saade GR, Thom E. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. A Randomized trial of intrapartum fetal ECG ST-segment analysis. N Engl J Med 2015; 373 (07) 632-641
  • 12 Zielinsky P, da Costa MH, Oliveira LT, Bonow FP, da Silva NI, Hagemann LL. [Natural history of myocardial hypertrophy and its association with hyperinsulinism in infants of diabetic mothers]. Arq Bras Cardiol 1997; 69 (06) 389-394
  • 13 Abu-Sulaiman RM, Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol 2004; 25 (02) 137-140
  • 14 El-Ganzoury MM, El-Masry SA, El-Farrash RA, Anwar M, Abd Ellatife RZ. Infants of diabetic mothers: echocardiographic measurements and cord blood IGF-I and IGFBP-1. Pediatr Diabetes 2012; 13 (02) 189-196
  • 15 Gonzalez AB, Young L, Doll JA, Morgan GM, Crawford SE, Plunkett BA. Elevated neonatal insulin-like growth factor I is associated with fetal hypertrophic cardiomyopathy in diabetic women. Am J Obstet Gynecol 2014; 211 (03) 290.e1-290.e7
  • 16 Sheehan PQ, Rowland TW, Shah BL, McGravey VJ, Reiter EO. Maternal diabetic control and hypertrophic cardiomyopathy in infants of diabetic mothers. Clin Pediatr (Phila) 1986; 25 (05) 266-271
  • 17 Sanhal CY, Daglar HK, Kara O, Uygur D, Yucel A. Assessment of fetal myocardial performance index in women with pregestational and gestational diabetes mellitus. J Obstet Gynaecol Res 2017; 43 (01) 65-72
  • 18 Palmieri CR, Simões MA, Silva JC, Santos AD, Silva MR, Ferreira B. Prevalence of hypertrophic cardiomyopathy in fetuses of mothers with gestational diabetes before initiating treatment. Rev Bras Ginecol Obstet 2017; 39 (01) 9-13
  • 19 Akbariasbagh P, Shariat M, Akbariasbagh N, Ebrahim B. Cardiovascular malformations in infants of diabetic mothers: a retrospective case-control study. Acta Med Iran 2017; 55 (02) 103-108
  • 20 Rijpert M, Breur JM, Evers IM. et al. Cardiac function in 7-8-year-old offspring of women with type 1 diabetes. Exp Diabetes Res 2011; 2011: 564316
  • 21 Sardesai MG, Gray AA, McGrath MM, Ford SE. Fatal hypertrophic cardiomyopathy in the fetus of a woman with diabetes. Obstet Gynecol 2001; 98 (5 Pt 2): 925-927
  • 22 Prefumo F, Celentano C, Presti F, De Biasio P, Venturini PL. Acute presentation of fetal hypertrophic cardiomyopathy in a type 1 diabetic pregnancy. Diabetes Care 2005; 28 (08) 2084
  • 23 Vincent M, Benbrik N, Romefort B, Colombel A, Bézieau S, Isidor B. Three patients presenting with severe macrosomia and congenital hypertrophic cardiomyopathy: a case series. J Med Case Reports 2017; 11 (01) 78
  • 24 Yli BM, Källén K, Stray-Pedersen B, Amer-Wåhlin I. Intrapartum fetal ECG and diabetes. J Matern Fetal Neonatal Med 2008; 21 (04) 231-238
  • 25 Welin AK, Blad S, Hagberg H, Rosén KG, Kjellmer I, Mallard C. Electrocardiographic changes following umbilical cord occlusion in the midgestation fetal sheep. Acta Obstet Gynecol Scand 2005; 84 (02) 122-128